Player FMアプリでオフラインにしPlayer FMう!
Chronic Heart Failure Drug Development Using Patient-Centric Chip Platform with Ayla Annac InvivoSciences
Manage episode 268926894 series 99915
Ayla Annac, CEO and Co-Founder, InvivoSciences shines light on the next generation of precision medicine and explains how IVS is personalizing the drug development process with patient-derived and gene-edited human samples. The company's Novel Heart Tissue on a chip platform NuHeart™ enables rapid identification of the safety and efficacy profile of a given treatment for a specific patient group. IVS is saving time and money in developing new therapies while increasing the success rate of approval for cardio safe therapies.
#COVID19 #ChronicHeartFailure
1733 つのエピソード
Manage episode 268926894 series 99915
Ayla Annac, CEO and Co-Founder, InvivoSciences shines light on the next generation of precision medicine and explains how IVS is personalizing the drug development process with patient-derived and gene-edited human samples. The company's Novel Heart Tissue on a chip platform NuHeart™ enables rapid identification of the safety and efficacy profile of a given treatment for a specific patient group. IVS is saving time and money in developing new therapies while increasing the success rate of approval for cardio safe therapies.
#COVID19 #ChronicHeartFailure
1733 つのエピソード
כל הפרקים
×プレーヤーFMへようこそ!
Player FMは今からすぐに楽しめるために高品質のポッドキャストをウェブでスキャンしています。 これは最高のポッドキャストアプリで、Android、iPhone、そしてWebで動作します。 全ての端末で購読を同期するためにサインアップしてください。